Inbiose
Universiteit Gent

Inbiose

Biotech
Biotech
Biotech
Biotech

Inbiose develops a fermentation-based production platform for the supply of specialty carbohydrates addressing wellness, nutrition, AgBio and BioMed needs.

Inbiose was founded mid 2013 as a spin-off from Ghent University. Inbiose develops a versatile fermentation-based production platform for the supply of specialty carbohydrates addressing wellness, nutrition, AgBio and BioMed needs. Specialty carbohydrates are high value added, rare and complex carbohydrates that are extremely hard to produce with conventional technologies (extraction, chemical or enzymatic synthesis). Though these powerful ingredients have been found to be essential for improving health in many areas, applications were hampered until today by the production cost and very limited availability. Inbiose can now tackle these technological issues, giving strong and reliable market perspectives.

No items found.
Marc Zabeau

Marc Zabeau

Managing Partner Qbic I

This company is aligned with the following SDGs

No items found.
Swave
Qbic III
Deeptech
Deeptech
Deeptech
Deeptech

Swave

Swave develops holographic eXtended reality technology to make virtual reality practically indistinguishable from the real world.

imec
VUB
Aloxy
Qbic II
Software
Software
Software
Software

Aloxy

Aloxy’s Internet of Things technology is enabling the petrochemical industry to innovate.

Universiteit Antwerpen
imec
THERAtRAME
Qbic III
Biotech
Biotech
Biotech
Biotech

THERAtRAME

THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.

ULiège